|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/21/2024 |
$67.78 |
$69.27 |
$67.38 |
$68.38 |
631.60K | 03/22/2024 |
$68.74 |
$69.90 |
$68.74 |
$69.02 |
821.20K | 03/25/2024 |
$69.59 |
$70.07 |
$67.82 |
$67.97 |
639.30K | 03/26/2024 |
$68.88 |
$69.27 |
$67.13 |
$67.33 |
303.70K | 03/27/2024 |
$67.94 |
$69.75 |
$67.50 |
$69.72 |
428.60K |
|
Intra-Cellular Therapies is a biopharmaceutical company focused on the discovery, clinical development and commercialization of small molecule drugs that address medical needs mainly in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. Co.'s product candidate, CAPLYTA (lumateperone) has been approved for the treatment of schizophrenia in adults. Co. is developing ITI-1284, an oral disintegrating tablet for sublingual administration for the treatment of behavioral disturbances in patients with dementia and dementia-related psychosis and for the treatment of certain depressive disorders in the elderly. | |
|
Intra-Cellular Therapies (ITCI) has the following price history information. Looking back at ITCI historical stock prices for the last five trading days, on March 21, 2024, ITCI opened at $67.78, traded as high as $69.27 and as low as $67.38, and closed at $68.38. Trading volume was a total of 631.60K shares. On March 22, 2024, ITCI opened at $68.74, traded as high as $69.90 and as low as $68.74, and closed at $69.02. Trading volume was a total of 821.20K shares. On March 25, 2024, ITCI opened at $69.59, traded as high as $70.07 and as low as $67.82, and closed at $67.97. Trading volume was a total of 639.30K shares. On March 26, 2024, ITCI opened at $68.88, traded as high as $69.27 and as low as $67.13, and closed at $67.33. Trading volume was a total of 303.70K shares. On March 27, 2024, ITCI opened at $67.94, traded as high as $69.75 and as low as $67.50, and closed at $69.72. Trading volume was a total of 428.60K shares.
ITCI Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Intra-Cellular Therapies shares, starting with a $10,000 purchase of ITCI, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$18.18 |
|
End price/share: |
$69.72 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
283.50% |
|
Average Annual Total Return: |
14.39% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$38,346.05 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/21/2024 | $68.38 | 03/22/2024 | $69.02 | 03/25/2024 | $67.97 | 03/26/2024 | $67.33 | 03/27/2024 | $69.72 |
|
|